1. Vakrakou, AG, Tzanetakos, D, Evangelopoulos, ME, et al. Clinico-radiologic features and therapeutic strategies in tumefactive demyelination: a retrospective analysis of 50 consecutive cases. Ther Adv Neurol Disord 2021; 14: 17562864211006503.
Google Scholar | SAGE Journals2. Hardy, TA, Reddel, SW, Barnett, MH, et al. Atypical inflammatory demyelinating syndromes of the CNS. Lancet Neurol 2016; 15: 967–981.
Google Scholar | Crossref | Medline | ISI3. Seifert, CL, Wegner, C, Sprenger, T, et al. Favourable response to plasma exchange in tumefactive CNS demyelination with delayed B-cell response. Mult Scler 2012; 18: 1045–1049.
Google Scholar | SAGE Journals | ISI4. Wallner-Blazek, M, Rovira, A, Fillipp, M, et al. Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis. J Neurol 2013; 260: 2016–2022.
Google Scholar | Crossref | Medline5. Mendez, MF, Pogacar, S. Malignant monophasic multiple sclerosis or ‘Marburg’s disease’. Neurology 1988; 38: 1153–1155.
Google Scholar | Crossref | Medline | ISI6. Suzuki, M, Kawasaki, H, Masaki, K, et al. An autopsy case of the Marburg variant of multiple sclerosis (acute multiple sclerosis). Intern Med 2013; 52: 1825–1832.
Google Scholar | Crossref | Medline7. Gladstone, DE, Golightly, MG, Brannagan, TH. High dose cyclophosphamide preferentially targets naïve T (CD45/CD4/RA+) cells in CIDP and MS patients. J Neuroimmunol 2007; 190: 121–126.
Google Scholar | Crossref | Medline8. Avila-Ornelas, J, Labat, E, Alfonso, G, et al. An extremely aggressive case of Marburg’s disease treated with high dose cyclophosphamide. A case report. Mult Scler Relat Disord 2019; 31: 51–53.
Google Scholar | Crossref | Medline9. Nozaki, K, Abou-Fayssal, N. High dose cyclophosphamide treatment in Marburg variant multiple sclerosis a case report. J Neurol Sci 2010; 296: 121–123.
Google Scholar | Crossref | Medline | ISI10. Vakrakou, AG, Tzanetakos, D, Argyrakos, T, et al. Recurrent fulminant tumefactive demyelination with Marburg-like features and atypical presentation: therapeutic dilemmas and review of literature. Front Neurol 2020; 11: 536.
Google Scholar | Crossref | Medline